All In Biotech

Drug Trial Radar · NCT05879614

An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)

An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)

Last checked: Nov 20, 2026Latest source record: Dec 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Sep 1, 2023

Primary completion

Jun 30, 2025

Study completion Jun 30, 2025

Sponsor

Lead sponsor
Neuren Pharmaceuticals LimitedIndustry
Sponsor type
Industry
First posted
May 30, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 4 years, up to 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A study of the safety, tolerability and pharmacokinetics of NNZ-2591 and measures of efficacy in children and adolescents with Prader-Willi Syndrome.

Conditions

  • Prader-Willi Syndrome

Interventions

  • NNZ-2591Drug

    NNZ-2591 oral solution (50mg/mL) to be administered twice daily for 13 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and TolerabilityTime frame: 13 weeks
  2. Pharmacokinetic - Measurement of CmaxTime frame: 13 weeks
  3. Pharmacokinetic - Measurement of AUCTime frame: 13 weeks
  4. Pharmacokinetic - Measurement of time to CmaxTime frame: 13 weeks
  5. Pharmacokinetic - Measurement of t1/2Time frame: 13 weeks

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Rady Children's Hospital San Diego

    San Diego, California

  • Rare Disease Research

    Atlanta, Georgia

  • Uncommon Cures

    Chevy Chase, Maryland

  • Suburban Research

    Media, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.